Association between body mass index and clinical outcomes after new-generation drug-eluting stent implantation: Korean multi-center registry data
Atherosclerosis Sep 07, 2018
Kim BG, et al. - Researchers examined how body mass index (BMI) impacts clinical outcome following percutaneous coronary intervention (PCI) with new-generation drug-eluting stents (DESs) by analyzing a total of 5,264 consecutive patients from four new-generation DES registries. These patients were divided into four categories according to BMI: underweight (BMI<18.5kg/m2, n=130), normal weight (18.5≤BMI < 25kg/m2, n=2,943), overweight (25 ≤ BMI< 30kg/m2, n=1932), and obese (BMI ≥ 30kg/m2, n=259). Outcomes reveal that there was a significant association with lower BMI and higher rates of major adverse cardiac and cerebrovascular event (MACCE) and all-cause mortality following PCI, so in Korean patients, the obesity paradox is seen in the new-generation DES era.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries